Search clinical trials for: XIENCE PRIME

Total 5851 results

Fundación EPIC

Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Coronary Artery Disease

Spain
Yonsei University

Recruiting

Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study

Myocardial Ischemia(Implanted Drug-eluting Stents Because of Ischemic Heart Disease(Stable Angina, Acute Coronary Syndrome))

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Sino Medical Sciences Technology Inc.

Completed

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

Coronary Artery Disease | Stable Angina Pectoris | Unstable Angina Pectoris

China
Abbott Medical Devices

Completed

AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population (ABSORB JAPAN)

Myocardial Ischemia | Coronary Artery Disease

Japan
Abbott Medical Devices

Completed

XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study (XP China SAS)

Myocardial Infarction | Coronary Artery Disease | Cardiovascular Disease | Coronary Heart Disease | Stent Thrombosis | Coronary Restenosis | Vascular Disease | Angioplasty

United States
Abbott Medical Devices

Completed

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Occlusion | Coronary Artery Stenosis | Angina

Japan
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Yonsei University
Gangwon Cardiovascular Health Research Institute

Terminated

BES, EES, and ZES-R in Real World Practice (CHOICE)

Coronary Artery Disease

Korea, Republic of
Iwate Medical University

Completed

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction (MECHANISM-AMI)

Coronary Artery Disease

Japan
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Completed

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Coronary Artery Disease

Korea, Republic of
Biotronik AG

Unknown

Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

Coronary Artery Disease

Latvia, Germany, Spain, Switzerland, Austria, France, Hungary, Netherlands
Abbott Medical Devices

Completed

EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO)

Coronary Artery Disease (CAD) | Chronic Total Occlusion (CTO)

United States
Seoul National University Hospital

Completed

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents (Grand-DES)

Coronary Artery Disease

Korea, Republic of
Meshalkin Research Institute of Pathology of Circulation

Completed

Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE (PATRIOT)

Coronary Artery Disease | Ischemic Heart Disease | Coronary Atherosclerosis | Coronary Artery Stenosis

Russian Federation
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Deutsches Herzzentrum Muenchen
Technical University of Munich

Completed

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography (ORSIRO_OCT)

Coronary Heart Disease

Germany
Universitaire Ziekenhuizen KU Leuven
Biosensors International

Unknown

COmplex BifuRcation Lesions: a Comparison Between the AXXESS Device and Culotte Stenting: an Optical Coherence Tomography (OCT) Study (COBRA)

True Coronary Bifurcation Lesions

Belgium
Fortis Escorts Heart Institute
Boston Scientific Corporation; Max Neeman Medical International Ltd.

Completed

Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics (Tuxedo)

Type 2 Diabetes | Coronary Heart Disease

India
R&D Cardiologie
Biotronik SE & Co. KG

Unknown

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis

Netherlands, Belgium
Seung-Jung Park
Abbott; CardioVascular Research Foundation, Korea

Terminated

LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Coronary Artery Disease

Korea, Republic of
Academisch Medisch Centrum - Universiteit van Amsterdam...
B. Braun Medical B.V.

Unknown

DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent.

In-stent Restenosis

Netherlands
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Sydney South West Area Health Service

Unknown

IVUS Controlled Stenting

Coronary Angioplasty and Stenting | Single de Novo Coronary Artery Stenoses

Australia
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Amsterdam UMC, location VUmc

Unknown

Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion:a Randomized H215O PET/CT Study (VANISH)

Coronary Artery Disease

Netherlands
Yonsei University

Completed

Impact of IntraVascular UltraSound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study)

Coronary Artery Disease

Korea, Republic of
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
A.O. Ospedale Papa Giovanni XXIII
Light Lab Imaging, Inc.

Completed

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial (OCTAVIA)

Acute Myocardial Infarction
Aarhus University Hospital Skejby
Medtronic; Abbott Medical Devices

Unknown

The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recross Study (DOCTOR Recross)

Coronary Disease

United Kingdom, Belgium, Denmark
Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Abbott Medical Devices

Completed

SPIRIT PRIME Clinical Trial (SPIRIT PRIME)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Coronary Artery Stenosis

United States, Australia
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg 2 (DESTINY 2)

Peripheral Arterial Disease

Germany, Australia, Belgium
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
Policlinico Casilino ASL RMB
Azienda Ospedaliero-Universitaria di Modena

Withdrawn

Outcome of Second Generation Drug-eLuting Stents in Patients With Diabetes Mellitus (OCELOT)

Coronary Artery Disease | Diabetes Mellitus

Italy
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
University Hospital, Basel, Switzerland

Completed

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

Coronary Artery Disease | Coronary Thrombosis

Denmark, Austria, Germany, Switzerland
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
Kobe University
Marquette University

Unknown

Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)

Coronary Heart Disease

Japan
Chonbuk National University Hospital

Unknown

COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease (COPERES)

Angioplasty, Balloon, Coronary

Korea, Republic of
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Seoul National University Hospital
Abbott

Unknown

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Coronary Artery Disease

Korea, Republic of
Yonsei University

Unknown

Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation (ANCHOR)

Coronary Artery Disease

Korea, Republic of
European Cardiovascular Research Center

Unknown

Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (PLATINUM+)

Ischemic Heart Disease | Coronary Artery Stenosis

Spain, Germany, France, United Kingdom, Italy, Netherlands, Macedonia, The Former Yugoslav Republic of, Switzerland
The First Affiliated Hospital of Soochow University

Not yet recruiting

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Multiple Myeloma | Newly Diagnosed | MRD | High Risk
Mayo Clinic

Not yet recruiting

Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States
Alexandria University

Recruiting

Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Ovarian Epithelial Cancer

Egypt

Search clinical trials for: XIENCE PRIME

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations